An important question that is often asked by clinicians is whether frailty should be measured once or repeatedly to better capture mortality risk? So far, epidemiological evidence on this topic is limited. In a study performed by EPI-FRAIL members Erwin Stolz and Emiel Hoogendijk, data from the LASA 75+ study were used to study whether current FI level or changes in FI better predicted mortality. The conclusion of the study was that “the rate of FI change was more important than the current FI level for short-term mortality prediction among the oldest old, which highlights the benefits of regular frailty assessments” (Stolz et al, 2022).
Please see the article in Age and Ageing for more information.